The Magazine for Sleep Professionals
Monday, March 9, 2026
Nexalin Technology, Inc. announced continued advancement toward its planned pivotal clinical trial evaluating HALO™ Clarity for the treatment of moderate to severe insomnia, designed to support Nexalin’s planned de novo submission to the U.S. Food and Drug Administration. The study is being conducted in collaboration with Lindus Health, a full-service clinical […]
SleepSpace (Proactive Life, Inc.), an AI-powered sleep technology company founded by NIH-funded sleep scientist Dr. Daniel Gartenberg, PhD, announced today it has been awarded a Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). The award supports development […]
Millions of people worldwide who suffer with chronic insomnia are all too familiar with its profound impact on cognitive function, mood, and overall health and well-being. Many of these patients have success with first-line treatments like cognitive behavioral therapy (CBT) and pharmacological interventions, but relief remains elusive for many with […]
Specific types of gut bacteria may increase or decrease the risk for insomnia, while insomnia itself may in turn alter the abundance of certain gut bacteria, a new study showed. However, outside experts challenged the investigators’ assertion that the link is causal. Investigators identified 14 groups of bacteria associated with increased […]
Poor sleep health affects a significant portion of the American population, with prevalent sleep-related issues impacting overall quality of life.1 A tiered approach to sleep health services is necessary, ranging from intensive interventions for severe cases to more widely accessible options for milder problems. Sleep coaching programs have emerged as […]
Daytime fatigue, psychological problems, and even traffic incidents are all linked to sleep disorders, prompting specialists to investigate work efficiency declines among up to 20% of young Australians impacted by sleep disorders. The recent research conducted by Flinders University utilized information from the West Australian longitudinal Raine Study Generation 2 […]
A study found a significant increase in the number of online search queries for “insomnia” between April and May 2020, when governments across the U.S. and around the world implemented stay-at-home orders in response to the COVID-19 pandemic. Results show there were 2.77 million Google searches for insomnia in the […]
Pear Therapeutics, Inc., announced the availability of Somryst™, the first prescription digital therapeutic (PDT) intended for use in the treatment of patients 22 years of age and older with chronic insomnia. Somryst addresses the underlying issues of chronic insomnia by delivering cognitive behavioral therapy for insomnia (CBTi), an evidence-based approach […]
June features the shortest nights of the year, but for those living with chronic insomnia, every night is long. That’s why the American Academy of Sleep Medicine (AASM), Society of Behavioral Sleep Medicine (SBSM) and American Alliance for Healthy Sleep (AAHS) are working to raise awareness of the disease with Insomnia Awareness Night […]
By Jacqueline Kloss, PhD In casual conversation, I find myself describing what I do professionally, and it goes something like this: I teach behavioral strategies and research ways to help individuals, especially women, overcome their sleep problems. All too often, I am met with the response of “That is what […]
